Reporting Manager
SOLEUS CAPITAL MASTER FUND, L.P.
Symbol
THTX
Shares outstanding
46,167,067 shares
Disclosed Ownership
4,801,375 shares
Ownership
10%
Form type
SCHEDULE 13D/A
Filing time
11 Apr 2025, 19:30:34 UTC
Date of event
11 Apr 2025

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 10% ownership in THERATECHNOLOGIES INC. Common Stock (THTX) on 11 Apr 2025."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13D/A for THERATECHNOLOGIES INC. Common Stock (THTX).
  • Disclosed ownership: 10%.
  • Date of event: 11 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Apr 2025, 19:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
SOLEUS CAPITAL MASTER FUND, L.P. 10% 4,801,375 0 4,801,375 /s/ Guy Levy Soleus Capital, LLC, Its General Partner 0001812275
SOLEUS CAPITAL, LLC 10% 4,801,375 0 4,801,375 /s/ Guy Levy Soleus Capital Group, LLC, Its Managing Member
SOLEUS CAPITAL GROUP, LLC 10% 4,801,375 0 4,801,375 /s/ Guy Levy Guy Levy, Managing Member
SOLEUS CAPITAL MANAGEMENT, L.P. 10% 4,801,375 0 4,801,375 /s/ Guy Levy Soleus GP, LLC, Its General Partner
SOLEUS GP, LLC 10% 4,801,375 0 4,801,375 /s/ Guy Levy Guy Levy, Managing Member
GUY LEVY 10% 4,801,375 0 4,801,375 /s/ Guy Levy Guy Levy